Skip to main content
SpringerLink
Log in

Immunopathology of urothelial lesions: immunological markers as predictive for clinical aggressiveness

  • Published:
World Journal of Urology Aims and scope Submit manuscript

Summary

Treatment of superficial bladder cancer is shifting toward a more conservative attitude with a widespread use of intravesical immunotherapy. There is a need for markers which can reliably identified patients at risk for progression for whom radical cystectomy remains the most effective treatment. Progress in immunopathology and definition of new tumor markers by hybridoma technology allow analysis of multiple prognostic indicators which may be clinically relevant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Slack NH, Prout GR Jr (1980) Heterogeneity of invasive bladder carcinoma and different responses to treatment. In: Bonney WW, Prout GR Jr (eds) AUA monographs, bladder cancer. Williams and Wilkins, Baltimore, p 213

    Google Scholar 

  2. Kaye KW, Lange PH (1982) Mode of presentation of invasive bladder cancer: reassessment of the problem. J Urol 128:31

    Google Scholar 

  3. DeCenzo JM, Howard P, Irish CE (1975) Antigen deletion and prognosis of patients with stage A transitional cell bladder carcinoma. J Urol 114:874

    Google Scholar 

  4. Tribukait B (1986) Diagnostic and prognostic significance of modal DNA-values and proportion of S-phase cells in human carcinoma of the bladder. In: Morphometry, stereology and image analysis in cancer cytology and histopathology. Elsevier (in press)

  5. Devonec M, Darzynkiewicz Z, Kostyrka-Claps ML, Collste L, Whitmore WF, Melamed MR (1982) Flow cytometry of low stage bladder tumors: correlation with cytologic and cystoscopic diagnosis. Cancer 49:109

    Google Scholar 

  6. Jakse G, Rauschmeier H, Rosmanith P, Hofstader (1983) Determination of carcinoembryonic antigen in tissue serum and urine in patients with transitional cell carcinoma of the urinary bladder. Urol Int 38:121

    Google Scholar 

  7. Tanaka T, Salmon DJ, Battifora H, Cline MJ (1986) Expression of p21 ras oncoproteins in human cancers. Cancer Res 46:1465

    Google Scholar 

  8. Coons AH, Kaplan MH (1950) Localization of antigens in tissue culture cells. II. Improvement in a method for the detection of antigen by means of fluorescent antibody. J Exp Med 93:1

    Google Scholar 

  9. Polak J, Van Noorden S (1983) Immunocytochemistry, practical application in pathology and biology. Wright, PSG

    Google Scholar 

  10. Bean MA, Bloom BR, Herberman RB, Old LJ, Oettgen HF, Klein G, Terry WD (1975) Cell mediated cytotoxicity for bladder carcinoma evaluation of a workshop. Cancer Res 35:2902

    Google Scholar 

  11. Hashimoto Y, Kitagawa HS (1979) Antigens characteristics of nitrosamine-induced urinary bladder cancer in rats. GANN 70:305

    Google Scholar 

  12. Masuko T, Yagita H, Hashimoto Y (1984) Monoclonal antibodies against cell surface antigens present of human urinary bladder cancer cells. JNCI 72:523

    Google Scholar 

  13. Fradet Y, Cordon-Cardo C, Whitmore WF Jr, Melamed MR, Old LJ (1986) Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics. Cancer Res 46:5183

    Google Scholar 

  14. Baricordi OR, Sensi A, De Vinci C, Melchiorri L, Fabris G, Marchetti E, Corrado F, Mattiuz PL, Pizza G (1985) A monoclonal antibody to human transitional-cell carcinoma of the bladder cross-reacting with a differentiation antigen of neutrophilic lineage. Int J Cancer 35:781

    Google Scholar 

  15. Chopin DK, de Kernion JB, Rosenthal DL, Fahey JL (1985) Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washings. J Urol 134:260

    Google Scholar 

  16. Rearden A, Naschtsheim DA, Frisman DM, Chiu P, Elmajian DA, Baird SM (1983) Altered cell surface antigen expression in bladder carcinoma detected by a new hemagglutinating monoclonal antibody. J Immunol 131:3073

    Google Scholar 

  17. Young D, Prout GR Jr, Lin C (1985) Production and characterization of mouse monoclonal antibodies to human bladder tumor associated antigens. Cancer Res 45:4439

    Google Scholar 

  18. Ben Aissa H, Paulie S, Koho H, Biberfeld P, Hansson Y, Lunblad ML, Gustafson H, Jonsdottir I, Perlmann P (1985) Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder. Br J Cancer 52:65

    Google Scholar 

  19. Summerhayes IC, Mclihinney RAJ, Ponder BAJ, Shearer RJ, Pocock RD (1985) Monoclonal antibodies raised against cell membrane components by human bladder tumor tissue recognizing subpopulation in normal urothelium. JNCI 75:1025

    Google Scholar 

  20. Thor A, Horanhand P, Wunderlich D, Caruso A, Muraro R, Schlom J (1984) Monoclonal antibodies define differential RAS gene expression in malignant and benign colonic disease. Nature (Lond) 311:562

    Google Scholar 

  21. Paulie S, Lundblad ML, Hansson Y, Koho H, Ben Aissa H, Perlmann P (1984) Production of antibodies to cellular antigens by EBV-transformed lymphocytes from patients with urinary bladder carcinoma. Scand J Immunol 20:461

    Google Scholar 

  22. Davidsohn I, Kovarik S, Ly N (1969) Isoantigen A, B and H in benign and malignant lesions of the cervix. Arch Pathol 87:306

    Google Scholar 

  23. Coombs RRA, Bedford D, Rouillard LM (1956) A and B blood group antigens on human epidermal cells demonstrated by mixed agglutination. Lancet 1:461

    Google Scholar 

  24. Catalona WJ (1981) Practical utility of specific red cell adherence test in bladder cancer. Urology 18:113

    Google Scholar 

  25. Stephenson TJ, Williams JL, Gelsthorpe K (1985) Monoclonal antibodies to detect A, B and H blood group isoantigens in superficial transitional cell carcinoma of the bladder: a means of predicting invasive recurrence. Br J Urol 57:148

    Google Scholar 

  26. Coon JS, Weinstein RS, Summers JL (1982) Blood group precursor T-antigen expression in human urinary bladder carcinoma. Am J Clin Pathol 77:692

    Google Scholar 

  27. Limas C, Lange P (1985) Lewis antigen in normal and neoplastic urothelium. Am J Clin Pathol 121:176

    Google Scholar 

  28. Nathrath WBJ, Arnholdt H, Wilson PD (1982) Keratin, luminal epithelial antigen and carcinoembryonic antigen in human urinary bladder carcinomas. Pathol Res Pract 175:299

    Google Scholar 

  29. Pocock RD, Ibrahim SK, Sloane JP, Ponder BAJ, Shearer RJ (1983) Potential value of antisera to epithelial membrane antigen in detecting early invasion in transitional cell carcinoma. Br J Urol 55:670

    Google Scholar 

  30. Jautzke G, Altenaehr E (1982) Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas. Cancer 50:2052

    Google Scholar 

  31. Summers JL, Coon JS, Ward RM, Falor WH, Miller III AW, Weinstein RS (1983) Prognosis in carcinoma of the urinary bladder based upon tissue blood group ABH and Thomsen-Freidenreich antigen status and karyotype of the initial tumor. Cancer Res 43:934

    Google Scholar 

  32. Whitmore KE, Chopin DK, Bubbers JEB, deKernion JB, Fahey JL (1987) Immunohistochemical of prediction of invasive recurrence of transitional cell carcinoma with a panel of tumor marker. J Urol (in press)

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Henri Mondor Hospital and Laboratory of Surgical Research, Paris XII University, F-94000, Creteil, France

    D. K. Chopin & C. C. Abbou

  2. Department of Surgery, Division of Urology, UCLA School of Medicine, 90024, Los Angeles, California, USA

    K. E. Whitmore & J. B. DeKernion

Authors
  1. D. K. Chopin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. E. Whitmore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. C. Abbou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. B. DeKernion
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chopin, D.K., Whitmore, K.E., Abbou, C.C. et al. Immunopathology of urothelial lesions: immunological markers as predictive for clinical aggressiveness. World J Urol 5, 133–137 (1987). https://doi.org/10.1007/BF00327071

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00327071

Keywords

Search

Navigation